M. Schiavoni

957 total citations
17 papers, 727 citations indexed

About

M. Schiavoni is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, M. Schiavoni has authored 17 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 5 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in M. Schiavoni's work include Hemophilia Treatment and Research (12 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). M. Schiavoni is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). M. Schiavoni collaborates with scholars based in Italy, Spain and Sweden. M. Schiavoni's co-authors include A. Gringeri, N. Ciavarella, Angiola Rocino, Pier Mannuccio Mannucci, Jan Astermark, Jerzy Windyga, R Musso, Mario von Depka, Francesco Inchingolo and Massimo Morfini and has published in prestigious journals such as Circulation, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

M. Schiavoni

17 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Schiavoni Italy 14 634 165 67 57 44 17 727
P. Y. Le Prise France 10 285 0.4× 112 0.7× 137 2.0× 35 0.6× 34 0.8× 19 495
K. W. Chan United States 10 262 0.4× 82 0.5× 23 0.3× 42 0.7× 43 1.0× 15 386
Michael S. Milder United States 7 144 0.2× 94 0.6× 43 0.6× 32 0.6× 69 1.6× 12 417
E. Koivunen Finland 14 252 0.4× 89 0.5× 102 1.5× 55 1.0× 25 0.6× 24 451
Ilya Kirgner Israel 10 119 0.2× 86 0.5× 53 0.8× 44 0.8× 47 1.1× 31 285
M. Kerowgan Germany 10 200 0.3× 61 0.4× 19 0.3× 34 0.6× 50 1.1× 16 359
Paola Marenco Italy 11 350 0.6× 189 1.1× 39 0.6× 39 0.7× 13 0.3× 21 506
Marta Lisa Battista Italy 12 355 0.6× 186 1.1× 12 0.2× 19 0.3× 27 0.6× 20 580
Seçkin Çağırgan Türkiye 9 187 0.3× 58 0.4× 56 0.8× 26 0.5× 33 0.8× 45 329
I. Khouri United States 9 347 0.5× 71 0.4× 60 0.9× 13 0.2× 13 0.3× 13 455

Countries citing papers authored by M. Schiavoni

Since Specialization
Citations

This map shows the geographic impact of M. Schiavoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schiavoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schiavoni more than expected).

Fields of papers citing papers by M. Schiavoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schiavoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schiavoni. The network helps show where M. Schiavoni may publish in the future.

Co-authorship network of co-authors of M. Schiavoni

This figure shows the co-authorship network connecting the top 25 collaborators of M. Schiavoni. A scholar is included among the top collaborators of M. Schiavoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schiavoni. M. Schiavoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Astermark, Jan, Carmen Altisent, Angelika Bátorová, et al.. (2010). Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report. Haemophilia. 16(5). 747–766. 102 indexed citations
2.
Gringeri, A., R Musso, Maria Gabriella Mazzucconi, et al.. (2007). Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Haemophilia. 13(4). 373–379. 69 indexed citations
3.
Astermark, Jan, Angiola Rocino, Mario von Depka, et al.. (2006). Current use of by‐passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors. Haemophilia. 13(1). 38–45. 43 indexed citations
4.
Astermark, Jan, Marta Morado, Angiola Rocino, et al.. (2006). Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors. Haemophilia. 12(4). 363–371. 87 indexed citations
5.
Šrámek, A., Paolo Bucciarelli, Augusto B. Federici, et al.. (2004). Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis. Circulation. 109(6). 740–744. 40 indexed citations
6.
Berrettini, Mauro, Giuliano Mariani, M. Schiavoni, et al.. (2001). Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.. PubMed. 86(6). 640–5. 46 indexed citations
7.
Bona, E. Di, M. Schiavoni, Giancarlo Castaman, N. Ciavarella, & Francesco Rodeghiero. (1997). Acquired haemophilia: experience of two Italian centres with 17 new cases. Haemophilia. 3(3). 183–188. 28 indexed citations
8.
Santagostino, Elena, P.M. Mannucci, A. Gringeri, et al.. (1997). Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization. Transfusion. 37(5). 517–522. 72 indexed citations
9.
Ciavarella, N., et al.. (1996). Use of Recombinant Factor VIla (NovoSeven®) in the Treatment of Two Patients with Type III von Willebrand’s Disease and an inhibitor against von Willebrand Factor. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 1). 150–154. 65 indexed citations
10.
Ciavarella, N., et al.. (1996). Immune tolerance in two high responder, severe hemophilia A patients with inhibitors: the importance of high doses and the duration of the treatment.. PubMed. 70 Suppl 1. 72–3. 2 indexed citations
11.
Hay, C. R. M., Jay N. Lozier, Michael Laffan, et al.. (1996). Safety Profile of Porcine Factor VIII and Its Use as Hospital and Home-Therapy for Patients with Haemophilia-A and Inhibitors: the Results of An International Survey. Thrombosis and Haemostasis. 75(1). 25–29. 71 indexed citations
12.
Santagostino, Elena, et al.. (1994). Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.. PubMed. 31(2 Suppl 4). 20–5. 25 indexed citations
13.
Morfini, Massimo, Pier Mannuccio Mannucci, N. Ciavarella, et al.. (1994). Prevalence of Infection with the Hepatitis C Virus among Italian Hemophiliacs before and after the Introduction of Virally Inactivated Clotting Factor Concentrates: A Retrospective Evaluation. Vox Sanguinis. 67(2). 178–182. 24 indexed citations
14.
Barbui, T, Guido Finazzi, Matteo Galli, et al.. (1993). Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): First report from the Italian Registry. 78(5). 313–318. 38 indexed citations
15.
Marchetti, Giovanna, P. Patracchini, Stefano Volinia, et al.. (1991). Characterization of the pseudogenic and genic homologous regions of von Willebrand factor. British Journal of Haematology. 78(1). 71–79. 1 indexed citations
16.
17.
Ciavarella, N., et al.. (1986). Effectiveness of Defibrotide for Prophylaxis of Deep Venous Thrombosis in Gynecological Surgery: A Double-Blind, Placebo-Controlled Clinical Trial. Pathophysiology of Haemostasis and Thrombosis. 16(Suppl. 1). 39–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Y. Le Prise Breakdown of academic impact, for papers by K. W. Chan Breakdown of academic impact, for papers by Michael S. Milder Breakdown of academic impact, for papers by E. Koivunen Breakdown of academic impact, for papers by Ilya Kirgner Breakdown of academic impact, for papers by M. Kerowgan Breakdown of academic impact, for papers by Paola Marenco Breakdown of academic impact, for papers by Marta Lisa Battista Breakdown of academic impact, for papers by Seçkin Çağırgan Breakdown of academic impact, for papers by I. Khouri
Rankless by CCL
2026